TABLE 3.

A summary of organisms and respective strains or cell lines used in the production of NVPNs.

Organism	Strain/Cell line	Protein nanocages	References
Bacteria (E. coli)	BL21 (DE3)	Dps	Allen et al. (2002), Suci et al. (2010)
		E2	Dalmau et al. (2009), Ren et al. (2012), Molino et al. (2013)
		Encapsulin	Moon et al. (2014)
		Ferritin	Palombarini et al. (2019), Silva et al. (2021), Wang et al. (2022)
		His6-HuHF and His6-SF nanocages	Gu et al. (2020)
		I3-01 nanocages	Hsia et al. (2016)
		Lumazine synthase	Ra et al. (2014)
		PepA	Kim et al. (2010)
		sHSP	Kim et al. (1998b), Kim R. et al. (1998), Bova et al. (2002), Flenniken et al. (2006), Choi et al. (2011)
		TIP60 nanocages	Ohara et al. (2023)
		TRAP nanocages	Malay et al. (2019), Naskalska et al. (2021)
	BL21 (DE3)B	sHSP	Flenniken et al. (2003)
	BL21 (DE3)-RIPL	I3-01 nanocages	Bruun et al. (2018)
	BL21 (DE3)C + RIL	E2	Peng and Lim (2011)
	BL21-Gold (DE3)	sHSP	Kawano et al. (2014), Guan et al. (2018), Kawano et al. (2018)
	BL21-CodonPlus (DE3)	sHSP	Murata et al. (2015)
	BL21-CodonPlus (DE3)-RIL	Ferritin	Johnson et al. (2005), Sana et al. (2010)
	JM109 (DE3)	sHSP	Wang et al. (2003)
	C43 (DE3)	Encapsulin	Cassidy-Amstutz et al. (2016)
Yeast (P. pastoris)	SMD1168	Vault	Wang et al. (2018)
Insect (Spodoptera frugiperda)	Sf9	Vault	Stephen et al. (2001), Kickhoefer et al. (2005), Poderycki et al. (2006), Champion et al. (2009), Kar et al. (2011), Kar et al. (2012), Wang et al. (2015)
Mammalian (Homo sapiens)	Human embryonic kidney 293F	Ferritin	Kanekiyo et al. (2013)
		Vault	Martín et al. (2022)